Advancing Science, Avoiding Harm: New Fed Rules to Raise Curtain on Clinical Trial Results
The Wall Street Journal today carried a piece about sweeping, new federal research disclosure rules aimed at beefing up the public accessibility of findings of clinical trials backed by billions in public dollars.
The regulations are targeting what Francis Collins, head of the National Institutes of Health (NIH), has called a "disappointing" record of pu…
Keep reading with a 7-day free trial
Subscribe to The California Stem Cell Report to keep reading this post and get 7 days of free access to the full post archives.